CTVA vs MCRB · P/E 42, rev $16.91B vs rev $1.1M
Corteva Inc (CTVA) versus Seres Therapeutics Inc (MCRB) — a side-by-side from cached financials, not a winner call.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Latest reported MCRB revenue for 2026-06-30 was $1.1M. Net income was -$15.3M. MCRB currently screens at market cap $109.8M.
CTVA currently screens at market cap $51.52B and trailing P/E 41.6. MCRB currently screens at market cap $109.8M.
Not investment advice. Open the CTVA and MCRB stock pages for the full models.
Not investment advice.